Test quickly measures efficacy of Alzheimer's drugs

04/13/2009 | Belleville News-Democrat (Ill.)

Researchers said a new called stable isotope-lined kinetics can assess the efficacy of a drug for Alzheimer's disease in only 36 hours. The test was used to show that an Eli Lilly and Co. drug, which is in late-stage trials, reduced the production of amyloid beta. The test might also be used toward hastening the development of Alzheimer's drugs, the researchers said.

View Full Article in:

Belleville News-Democrat (Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX